Previous Article | Next Article 
Journal of Virology, December 2004, p. 13812-13818, Vol. 78, No. 24
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.24.13812-13818.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Hepatitis B Virus Nucleocapsids Formed by Carboxy-Terminally Mutated Core Proteins Contain Spliced Viral Genomes but Lack Full-Size DNA
Josef Köck,1
Michael Nassal,1
Karl Deres,2
Hubert E. Blum,1 and
Fritz von Weizsäcker1*
Department of Medicine II, University of Freiburg,1
Department of Virology, Bayer AG, Wuppertal, Germany2
Received 19 February 2004/
Accepted 8 August 2004
The carboxy-terminal sequence of the hepatitis B virus (HBV) core protein constitutes a nucleic acid binding domain that is rich in arginine residues and contains three serine phosphorylation sites. While dispensable for capsid assembly, this domain is involved in viral replication, as demonstrated by the effects of mutations on RNA packaging and/or reverse transcription; however, the underlying mechanisms are poorly understood. Here we tested a series of core protein mutants in which the three serine phosphorylation sites were replaced by glutamic acid, in parallel with a previously described deletion variant lacking the 19 C-terminal amino acid residues, for their ability to support viral replication in transfected hepatoma cells. Replacement of all serines and the deletion gave rise to nucleocapsids containing a smaller than wild-type DNA genome. Rather than a single-stranded DNA intermediate, as previously thought, this was a 2.0-kbp double-stranded DNA molecule derived from spliced pregenomic RNA (pgRNA). Interestingly, full-length pgRNA was associated with nucleocapsids but was found to be sensitive to nuclease digestion, while encapsidated spliced RNA and 3' truncated RNA species were nuclease resistant. These findings suggest that HBV pgRNA encapsidation is directional and that a packaging limit is determined by the C-terminal portion of the core protein.
* Corresponding author. Mailing address: Department of Medicine II, University of Freiburg, Hugstetter Strasse 55, D-79106 Freiburg, Germany. Phone: 49 761 2703401. Fax: 49 761 2703610. E-mail:
fritz.weizsaecker{at}uniklinik-freiburg.de.
Journal of Virology, December 2004, p. 13812-13818, Vol. 78, No. 24
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.24.13812-13818.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Newman, M., Chua, P. K., Tang, F.-M., Su, P.-Y., Shih, C.
(2009). Testing an Electrostatic Interaction Hypothesis of Hepatitis B Virus Capsid Stability by Using an In Vitro Capsid Disassembly/Reassembly System. J. Virol.
83: 10616-10626
[Abstract]
[Full Text]
-
Nassal, M., Leifer, I., Wingert, I., Dallmeier, K., Prinz, S., Vorreiter, J.
(2007). A Structural Model for Duck Hepatitis B Virus Core Protein Derived by Extensive Mutagenesis. J. Virol.
81: 13218-13229
[Abstract]
[Full Text]
-
Lewellyn, E. B., Loeb, D. D.
(2007). Base Pairing between cis-Acting Sequences Contributes to Template Switching during Plus-Strand DNA Synthesis in Human Hepatitis B Virus. J. Virol.
81: 6207-6215
[Abstract]
[Full Text]
-
Basagoudanavar, S. H., Perlman, D. H., Hu, J.
(2007). Regulation of Hepadnavirus Reverse Transcription by Dynamic Nucleocapsid Phosphorylation. J. Virol.
81: 1641-1649
[Abstract]
[Full Text]
-
Melegari, M., Wolf, S. K., Schneider, R. J.
(2005). Hepatitis B Virus DNA Replication Is Coordinated by Core Protein Serine Phosphorylation and HBx Expression. J. Virol.
79: 9810-9820
[Abstract]
[Full Text]
-
Wieland, S. F., Eustaquio, A., Whitten-Bauer, C., Boyd, B., Chisari, F. V.
(2005). Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc. Natl. Acad. Sci. USA
102: 9913-9917
[Abstract]
[Full Text]
-
Perlman, D. H., Berg, E. A., O'Connor, P. B., Costello, C. E., Hu, J.
(2005). Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids. Proc. Natl. Acad. Sci. USA
102: 9020-9025
[Abstract]
[Full Text]